These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6923744)

  • 1. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis.
    Mitchell EA; Quested C; Marks RE; Pinnock RE; Elliott RB
    Aust Paediatr J; 1982 Jun; 18(2):114-7. PubMed ID: 6923744
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic enzyme supplement dosage in cystic fibrosis.
    Owen G; Peters TJ; Dawson S; Goodchild MC
    Lancet; 1991 Nov; 338(8775):1153. PubMed ID: 1682579
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
    Gow R; Bradbear R; Francis P; Shepherd R
    Lancet; 1981 Nov; 2(8255):1071-4. PubMed ID: 6118524
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
    Zsíros J; Sólyom E
    Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773
    [No Abstract]   [Full Text] [Related]  

  • 6. Malabsorption in cystic fibrosis: mechanisms and treatment.
    Bouquet J; Sinaasappel M; Neijens HJ
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S30-5. PubMed ID: 3404359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
    Dutta SK; Tilley DK
    J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis.
    Warwick WJ; Budd JR
    Clin Ther; 1982; 5(1):15-20. PubMed ID: 7127365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study.
    Vyas H; Matthew DJ; Milla PJ
    Eur J Pediatr; 1990 Jan; 149(4):241-3. PubMed ID: 1689245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
    Cho YW; Aviado DM
    J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
    N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating.
    Marotta F; O'Keefe SJ; Marks IN; Girdwood A; Young G
    Dig Dis Sci; 1989 Mar; 34(3):456-61. PubMed ID: 2563963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does enzyme substitution therapy reduce pain in chronic pancreatitis?].
    Hansen ML; Rumessen JJ
    Ugeskr Laeger; 2005 Apr; 167(17):1841-4. PubMed ID: 15929329
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term treatment of mucoviscidosis. Results with a microencapsulated pancreatic enzyme preparation].
    Henker J; Hoffmann D; Paul D; Hein J; Paditz E
    Fortschr Med; 1993 Feb; 111(4):53-6. PubMed ID: 8449468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of steatorrhoea in cystic fibrosis: a comparison of enteric-coated microspheres of pancreatin versus non-enteric-coated pancreatin and adjuvant cimetidine.
    Stead RJ; Skypala I; Hodson ME
    Aliment Pharmacol Ther; 1988 Dec; 2(6):471-82. PubMed ID: 2979269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation.
    Stead RJ; Skypala I; Hodson ME; Batten JC
    Thorax; 1987 Jul; 42(7):533-7. PubMed ID: 3326213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in the treatment of exocrine pancreatic insufficiency.
    DiMagno EP
    Dig Dis Sci; 1982 Jun; 27(6):481-4. PubMed ID: 6919479
    [No Abstract]   [Full Text] [Related]  

  • 18. The management of enzymatic therapy in cystic fibrosis patients by an individualized approach.
    Costantini D; Padoan R; Curcio L; Giunta A
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S36-9. PubMed ID: 3404360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic enzyme replacement therapy.
    Morrow JD
    Am J Med Sci; 1989 Nov; 298(5):357-9. PubMed ID: 2683774
    [No Abstract]   [Full Text] [Related]  

  • 20. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
    Zerega J; Lerner S; Meyer JH
    Dig Dis Sci; 1988 Oct; 33(10):1245-9. PubMed ID: 3168697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.